{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:23Z","timestamp":1792603103046,"version":"4.5.0"},"reference-count":111,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Uterine fibroids (UFs), leiomyomas or myomas, are a type of malignancy that affects the smooth muscle of the uterus, and it is most commonly detected in women of reproductive age. Uterine fibroids are benign monoclonal growths that emerge from uterine smooth muscle cells (myometrium) as well as fibroblasts. Uterine fibroid symptoms include abnormal menstrual bleeding leading to anaemia, tiredness, chronic vaginal discharge, and pain during periods. Other symptoms include protrusion of the abdomen, pain during intercourse, dysfunctions of bladder\/bowel leading to urinary incontinence\/retention, pain, and constipation. It is also associated with reproductive issues like impaired fertility, conceiving complications, and adverse obstetric outcomes. It is the leading cause of gynaecological hospitalisation in the American subcontinent and a common reason for the hysterectomy. Twenty-five percent of the reproductive women experience the symptoms of uterine fibroids, and among them, around 25% require hospitalization due to the severity of the disease. The frequency of the disease remains underestimated as many women stay asymptomatic and symptoms appear gradually; therefore, the condition remains undiagnosed. The exact frequency of uterine fibroids varies\u00a0depending on the diagnosis, and the population investigated; nonetheless, the incidence of uterine fibroids in reproductive women ranges from 5.4 percent to 77 percent. The uterine fibroid treatment included painkillers, supplementation with iron, vitamin D3, birth control, hormone therapy, gonadotropin-releasing hormone (GnRH) agonists, drugs modulating the estrogen receptors, and surgical removal of the fibroids. However, more research needed at the level of gene to get a keen insight and treat the\u00a0disease efficiently.<\/jats:p>","DOI":"10.1515\/jbcpp-2022-0219","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T11:55:02Z","timestamp":1680090902000},"page":"291-310","source":"Crossref","is-referenced-by-count":71,"title":["Diagnosis and management of uterine fibroids: current trends and future strategies"],"prefix":"10.1515","volume":"34","author":[{"given":"Azaz","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"},{"name":"Department of Reproductive Medicine , Indira IVF Hospital Pvt Ltd , Udaipur , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Centre for Translational and Clinical Research , School of Chemical and Life Sciences, Jamia Hamdard , New Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihar Ranjan","family":"Bhoi","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine , Indira IVF Hospital Pvt Ltd , Udaipur , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Badruddeen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juber","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Irfan","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Ajmal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1776-6294","authenticated-orcid":false,"given":"Mohammad","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Integral University , Lucknow , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_001","doi-asserted-by":"crossref","unstructured":"Ryan, GL, Syrop, CH, Van Voorhis, BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 2005;48:312\u201324. https:\/\/doi.org\/10.1097\/01.grf.0000159538.27221.8c.","DOI":"10.1097\/01.grf.0000159538.27221.8c"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_002","doi-asserted-by":"crossref","unstructured":"Sankaran, S, Manyonda, IT. Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22:655\u201376. https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.03.001.","DOI":"10.1016\/j.bpobgyn.2008.03.001"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_003","doi-asserted-by":"crossref","unstructured":"Rein, MS, Barbieri, RL, Friedman, AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172:14\u20138. https:\/\/doi.org\/10.1016\/0002-9378(95)90077-2.","DOI":"10.1016\/0002-9378(95)90077-2"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_004","doi-asserted-by":"crossref","unstructured":"Fields, KR, Neinstein, LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol 1996;9:195\u20138. https:\/\/doi.org\/10.1016\/s1083-3188(96)70030-x.","DOI":"10.1016\/S1083-3188(96)70030-X"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_005","doi-asserted-by":"crossref","unstructured":"Cramer, SF, Patel, A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435\u20138. https:\/\/doi.org\/10.1093\/ajcp\/94.4.435.","DOI":"10.1093\/ajcp\/94.4.435"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_006","doi-asserted-by":"crossref","unstructured":"Donnez, J, Dolmans, MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22:665\u201386. https:\/\/doi.org\/10.1093\/humupd\/dmw023.","DOI":"10.1093\/humupd\/dmw023"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_007","doi-asserted-by":"crossref","unstructured":"Laughlin, SK, Schroeder, JC, Baird, DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204. https:\/\/doi.org\/10.1055\/s-0030-1251477.","DOI":"10.1055\/s-0030-1251477"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_008","doi-asserted-by":"crossref","unstructured":"Zhou, M, Wang, H, Zhu, J, Chen, W, Wang, L, Liu, S, et al.. Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the global burden of disease study 2013. Lancet 2016;387:251\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(15)00551-6.","DOI":"10.1016\/S0140-6736(15)00551-6"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_009","doi-asserted-by":"crossref","unstructured":"Investigators Rest. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007;356:360\u201370.","DOI":"10.1056\/NEJMoa062003"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_010","doi-asserted-by":"crossref","unstructured":"Fuldeore, MJ, Soliman, AM. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis. Int J Womens Health 2017;9:403. https:\/\/doi.org\/10.2147\/ijwh.s133212.","DOI":"10.2147\/IJWH.S133212"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_011","unstructured":"Uhunmwangho, EA. Barriers to treatment of symptomatic uterine fibroids among African American women. Doctoral Dissertation. Capella University; 2016."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_012","doi-asserted-by":"crossref","unstructured":"Eltoukhi, HM, Modi, MN, Weston, M, Armstrong, AY, Stewart, EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol 2014;210:194\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2013.08.008.","DOI":"10.1016\/j.ajog.2013.08.008"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_013","doi-asserted-by":"crossref","unstructured":"Baird, DD, Dunson, DB. Why is parity protective for uterine fibroids? Epidemiology 2003;14:247\u201350. https:\/\/doi.org\/10.1097\/01.ede.0000054360.61254.27.","DOI":"10.1097\/01.EDE.0000054360.61254.27"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_014","doi-asserted-by":"crossref","unstructured":"Oscan, A, Kopuz, A, Turan, V, Sahin, C, Emrah, T, Aksoy, S, et al.. Cesarean myomectomy for solitary uterine fibroids: is it a safe procedure? Ginekol Pol 2016;87:54\u20138. https:\/\/doi.org\/10.17772\/gp\/57833.","DOI":"10.17772\/gp\/57833"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_015","doi-asserted-by":"crossref","unstructured":"Nayak, S, Dash, SP, Khatua, M. Uterine sub mucosal leiomyoma (fibroid)-A case report. IOSR J Dent Med Sci 2014;13:17\u201321. https:\/\/doi.org\/10.9790\/0853-131251721.","DOI":"10.9790\/0853-131251721"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_016","unstructured":"Reynolds, A. Diagnosis and management of uterine fibroids. Radiol Technol 2007;79:157\u201378."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_017","doi-asserted-by":"crossref","unstructured":"Parazzini, F. Risk factors for clinically diagnosed uterine fibroids in women around menopause. Maturitas 2006;55:174\u20139. https:\/\/doi.org\/10.1016\/j.maturitas.2006.01.013.","DOI":"10.1016\/j.maturitas.2006.01.013"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_018","doi-asserted-by":"crossref","unstructured":"Burbank, F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology? J Am Assoc Gynecol Laparoscopists 2004;11:138\u201352. https:\/\/doi.org\/10.1016\/s1074-3804(05)60189-2.","DOI":"10.1016\/S1074-3804(05)60189-2"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_019","doi-asserted-by":"crossref","unstructured":"Schwartz, SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol 2001;44:316\u201326. https:\/\/doi.org\/10.1097\/00003081-200106000-00018.","DOI":"10.1097\/00003081-200106000-00018"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_020","doi-asserted-by":"crossref","unstructured":"Purdie, DM, Green, AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001;15:341\u201354. https:\/\/doi.org\/10.1053\/beog.2000.0180.","DOI":"10.1053\/beog.2000.0180"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_021","doi-asserted-by":"crossref","unstructured":"Wise, LA, Palmer, JR, Harlow, BL, Spiegelman, D, Stewart, EA, Adams-Campbell, LL, et al.. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the black women\u2019s health study. Hum Reprod 2004;19:1746\u201354. https:\/\/doi.org\/10.1093\/humrep\/deh309.","DOI":"10.1093\/humrep\/deh309"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_022","unstructured":"Sparic, R, Mirkovic, L, Malvasi, A, Tinelli, A. Epidemiology of uterine myomas: a review. Int J Fertil Steril 2016;9:424. https:\/\/doi.org\/10.22074\/ijfs.2015.4599."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_023","doi-asserted-by":"crossref","unstructured":"Marshall, LM, Spiegelman, D, Manson, JE, Goldman, MB, Barbieri, RL, Stampfer, MJ, et al.. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 1998;1:511\u20137. https:\/\/doi.org\/10.1097\/00001648-199809000-00007.","DOI":"10.1097\/00001648-199809000-00007"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_024","doi-asserted-by":"crossref","unstructured":"Templeman, C, Marshall, SF, Clarke, CA, Henderson, KD, Largent, J, Neuhausen, S, et al.. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril 2009;92:1436\u201346. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.08.074.","DOI":"10.1016\/j.fertnstert.2008.08.074"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_025","doi-asserted-by":"crossref","unstructured":"Zhu, BT, Conney, AH. Functional role of estrogens metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1\u201327. https:\/\/doi.org\/10.1093\/carcin\/19.1.1.","DOI":"10.1093\/carcin\/19.1.1"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_026","doi-asserted-by":"crossref","unstructured":"Pavone, D, Clemenza, S, Sorbi, F, Fambrini, M, Petraglia, F. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2018;46:3\u201311. https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.09.004.","DOI":"10.1016\/j.bpobgyn.2017.09.004"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_027","doi-asserted-by":"crossref","unstructured":"Baird, DD, Dunson, DB, Hill, MC, Cousins, D, Schectman, JM. Association of physical activity with development of uterine leiomyoma. Am J\u00a0Epidemiol 2007;165:157\u201363. https:\/\/doi.org\/10.1093\/aje\/kwj363.","DOI":"10.1093\/aje\/kwj363"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_028","doi-asserted-by":"crossref","unstructured":"Chiaffarino, F, Ricci, E, Cipriani, S, Chiantera, V, Parazzini, F. Cigarette smoking and risk of uterine myoma: systematic review and meta-analysis. Eur J Obstet Gynecol 2016;197:63\u201371. https:\/\/doi.org\/10.1016\/j.ejogrb.2015.11.023.","DOI":"10.1016\/j.ejogrb.2015.11.023"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_029","doi-asserted-by":"crossref","unstructured":"Tofovic, SP, Jackson, EK. Oestradiol metabolism: crossroads in pulmonary arterial hypertension. Int J Mol Sci 2020;21:116. https:\/\/doi.org\/10.3390\/ijms21010116.","DOI":"10.3390\/ijms21010116"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_030","doi-asserted-by":"crossref","unstructured":"Gupta, S, Jose, J, Manyonda, I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22:615\u201326. https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.01.008.","DOI":"10.1016\/j.bpobgyn.2008.01.008"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_031","doi-asserted-by":"crossref","unstructured":"Pezzuto, A, Serboli, G, Ceccaroni, M, Ferrari, B, Nardelli, GB, Minelli, LL. Two case reports of bowel leiomyomas and review of literature. Gynecol Endocrinol 2010;26:894\u20136. https:\/\/doi.org\/10.3109\/09513590.2010.488767.","DOI":"10.3109\/09513590.2010.488767"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_032","doi-asserted-by":"crossref","unstructured":"Whitaker, L, Critchley, HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2016;34:54\u201365. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.012.","DOI":"10.1016\/j.bpobgyn.2015.11.012"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_033","doi-asserted-by":"crossref","unstructured":"Shwayder, JM. Pathophysiology of abnormal uterine bleeding. Obstet Gynecol Clin N Am 2000;27:219\u201334. https:\/\/doi.org\/10.1016\/s0889-8545(00)80017-0.","DOI":"10.1016\/S0889-8545(00)80017-0"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_034","doi-asserted-by":"crossref","unstructured":"Pasricha, SR, Flecknoe\u2010Brown, SC, Allen, KJ, Gibson, PR, McMahon, LP, Olynyk, JK, et al.. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2010;193:525\u201332. https:\/\/doi.org\/10.5694\/j.1326-5377.2010.tb04038.x.","DOI":"10.5694\/j.1326-5377.2010.tb04038.x"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_035","doi-asserted-by":"crossref","unstructured":"Stovall, DW. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol 2001;44:364\u201371. https:\/\/doi.org\/10.1097\/00003081-200106000-00022.","DOI":"10.1097\/00003081-200106000-00022"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_036","doi-asserted-by":"crossref","unstructured":"Khan, AT, Shehmar, M, Gupta, JK. Uterine fibroids: current perspectives. Int J Wom Health 2014;6:95. https:\/\/doi.org\/10.2147\/ijwh.s51083.","DOI":"10.2147\/IJWH.S51083"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_037","doi-asserted-by":"crossref","unstructured":"Lippman, SA, Warner, M, Samuels, S, Olive, D, Vercellini, P, Eskenazi, B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 2003;80:1488\u201394. https:\/\/doi.org\/10.1016\/s0015-0282(03)02207-6.","DOI":"10.1016\/S0015-0282(03)02207-6"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_038","doi-asserted-by":"crossref","unstructured":"Montenegro, ML, Vasconcelos, EC, Candido Dos Reis, FJ, Nogueira, AA, Poli\u2010Neto, OB. Physical therapy in the management of women with chronic pelvic pain. Int J Clin Pract 2008;62:263\u20139. https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01530.x.","DOI":"10.1111\/j.1742-1241.2007.01530.x"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_039","doi-asserted-by":"crossref","unstructured":"Bukulmez, O, Doody, KJ. Clinical features of myomas. Obstet Gynecol Clin N Am 2006;33:69\u201384. https:\/\/doi.org\/10.1016\/j.ogc.2005.12.002.","DOI":"10.1016\/j.ogc.2005.12.002"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_040","doi-asserted-by":"crossref","unstructured":"Wallach, EE, Vlahos, NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004;104:393\u2013406. https:\/\/doi.org\/10.1097\/01.aog.0000136079.62513.39.","DOI":"10.1097\/01.AOG.0000136079.62513.39"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_041","doi-asserted-by":"crossref","unstructured":"Cvach, K, Dwyer, P, Rosamilia, A, Lim, Y, Schierlitz, L. A prospective observational study of lower urinary tract symptoms before and after surgical removal of a large pelvic mass. Int Urogynecol J 2015;26:201\u20136. https:\/\/doi.org\/10.1007\/s00192-014-2463-1.","DOI":"10.1007\/s00192-014-2463-1"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_042","doi-asserted-by":"crossref","unstructured":"Timmerman, D. The use of mathematical models to evaluate pelvic masses; can they beat an expert operator? Best Pract Res Clin Obstet Gynaecol 2004;18:91\u2013104. https:\/\/doi.org\/10.1016\/j.bpobgyn.2003.09.009.","DOI":"10.1016\/j.bpobgyn.2003.09.009"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_043","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril 2004;82(1\u00a0Suppl):S111\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.05.061.","DOI":"10.1016\/j.fertnstert.2004.05.061"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_044","doi-asserted-by":"crossref","unstructured":"Zepiridis, LI, Grimbizis, GF, Tarlatzis, BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2016;34:66\u201373. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.12.001.","DOI":"10.1016\/j.bpobgyn.2015.12.001"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_045","doi-asserted-by":"crossref","unstructured":"Munro, MG, Critchley, HO, Broder, MS, Fraser, IS. FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 2011;113:3\u201313. https:\/\/doi.org\/10.1016\/j.ijgo.2010.11.011.","DOI":"10.1016\/j.ijgo.2010.11.011"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_046","doi-asserted-by":"crossref","unstructured":"Mukhopadhaya, N, Asante, GP, Manyonda, IT. Uterine fibroids: impact on fertility and pregnancy loss. Obstet Gynaecol Reprod Med 2007;17:311\u20137. https:\/\/doi.org\/10.1016\/j.ogrm.2007.08.005.","DOI":"10.1016\/j.ogrm.2007.08.005"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_047","doi-asserted-by":"crossref","unstructured":"Lumsden, MA, Wallace, EM. 2 Clinical presentation of uterine fibroids. Bailliere Clin Obstet Gynaecol 1998;12:177\u201395. https:\/\/doi.org\/10.1016\/s0950-3552(98)80060-6.","DOI":"10.1016\/S0950-3552(98)80060-6"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_048","doi-asserted-by":"crossref","unstructured":"Rai, R, Regan, L. Recurrent miscarriage. Lancet 2006;368:601\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(06)69204-0.","DOI":"10.1016\/S0140-6736(06)69204-0"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_049","doi-asserted-by":"crossref","unstructured":"Schwartz, PE, Kelly, MG. Malignant transformation of myomas: myth or reality? Obstet Gynecol Clin 2006;33:183\u201398. https:\/\/doi.org\/10.1016\/j.ogc.2005.12.003.","DOI":"10.1016\/j.ogc.2005.12.003"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_050","doi-asserted-by":"crossref","unstructured":"Turocy, JM, Rackow, BW. Uterine factor in recurrent pregnancy loss. Semin Perinatol 2019;43:74\u20139. WB Saunders.","DOI":"10.1053\/j.semperi.2018.12.003"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_051","doi-asserted-by":"crossref","unstructured":"Campo, S, Campo, V, Gambadauro, P. Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas. Eur J Obstet Gynecol Reprod Biol 2003;110:215\u20139. https:\/\/doi.org\/10.1016\/s0301-2115(03)00159-3.","DOI":"10.1016\/S0301-2115(03)00159-3"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_052","doi-asserted-by":"crossref","unstructured":"Schwartz, SM, Marshall, LM, Baird, DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108(5 Suppl):821\u20137. https:\/\/doi.org\/10.2307\/3454313.","DOI":"10.1289\/ehp.00108s5821"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_053","doi-asserted-by":"crossref","unstructured":"Ligon, AH, Morton, CC. Genetics of uterine leiomyomata. Gene Chromosome Cancer 2000;28:235\u201345.","DOI":"10.1002\/1098-2264(200007)28:3<235::AID-GCC1>3.3.CO;2-Z"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_054","doi-asserted-by":"crossref","unstructured":"Walker, CL, Stewart, EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589\u201392. https:\/\/doi.org\/10.1126\/science.1112063.","DOI":"10.1126\/science.1112063"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_055","doi-asserted-by":"crossref","unstructured":"Garcia, L, Isaacson, K. Adenomyosis: review of the literature. J Minim Invasive Gynecol 2011;18:428\u201337. https:\/\/doi.org\/10.1016\/j.jmig.2011.04.004.","DOI":"10.1016\/j.jmig.2011.04.004"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_056","doi-asserted-by":"crossref","unstructured":"Alkatout, I, Honemeyer, U, Strauss, A, Tinelli, A, Malvasi, A, Jonat, W, et al.. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv 2013;68:571\u201381. https:\/\/doi.org\/10.1097\/ogx.0b013e31829cdbeb.","DOI":"10.1097\/OGX.0b013e31829cdbeb"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_057","doi-asserted-by":"crossref","unstructured":"Di Cristofano, A, Ellenson, LH. Endometrial carcinoma. Annu Rev Pathol 2007;2:57\u201385. https:\/\/doi.org\/10.1146\/annurev.pathol.2.010506.091905.","DOI":"10.1146\/annurev.pathol.2.010506.091905"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_058","doi-asserted-by":"crossref","unstructured":"Salim, S, Won, H, Nesbitt-Hawes, E, Campbell, N, Abbott, J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol 2011;18:569\u201381. https:\/\/doi.org\/10.1016\/j.jmig.2011.05.018.","DOI":"10.1016\/j.jmig.2011.05.018"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_059","doi-asserted-by":"crossref","unstructured":"Symons, LK, Miller, JE, Kay, VR, Marks, RM, Liblik, K, Koti, M, et al.. The immunopathophysiology of endometriosis. Trends Mol Med 2018;24:748\u201362. https:\/\/doi.org\/10.1016\/j.molmed.2018.07.004.","DOI":"10.1016\/j.molmed.2018.07.004"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_060","doi-asserted-by":"crossref","unstructured":"Serrano, C, George, S. Leiomyosarcoma. Hematol Oncol Clin. 2013;27:957\u201374. https:\/\/doi.org\/10.1016\/j.hoc.2013.07.002.","DOI":"10.1016\/j.hoc.2013.07.002"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_061","doi-asserted-by":"crossref","unstructured":"Vahdat, M, Allahqoli, L, Mirzaei, H, Giovannucci, E, Salehiniya, H, Mansouri, G, et al.. The effect of vitamin D on recurrence of uterine fibroids: a randomized, double-blind, placebo-controlled pilot study. Compl Ther Clin Pract 2022;46:101536. https:\/\/doi.org\/10.1016\/j.ctcp.2022.101536.","DOI":"10.1016\/j.ctcp.2022.101536"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_062","doi-asserted-by":"crossref","unstructured":"Parazzini, F, Tozzi, L, Bianchi, S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2016;34:74\u201384. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.017.","DOI":"10.1016\/j.bpobgyn.2015.11.017"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_063","unstructured":"Mobeen, S, Apostol, R. Ovarian Cyst. InStatPearls [Internet] 2022 Jun 13. StatPearls Publishing."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_064","doi-asserted-by":"crossref","unstructured":"Ak\u0131nc\u0131, D, Ergun, O, Topel, \u00c7, \u00c7ift\u00e7i, T, Akhan, O. Pelvic abscess drainage: outcome with factors affecting the clinical success. Diagn Interventional Radiol 2018;24:146. https:\/\/doi.org\/10.5152\/dir.2018.16500.","DOI":"10.5152\/dir.2018.16500"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_065","doi-asserted-by":"crossref","unstructured":"M\u00e1rmol, I, S\u00e1nchez-de-Diego, C, Pradilla Dieste, A, Cerrada, E, Rodriguez Yoldi, MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 2017;18:197. https:\/\/doi.org\/10.3390\/ijms18010197.","DOI":"10.3390\/ijms18010197"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_066","unstructured":"Kaganov, H, Ades, A. Uterine fibroids: investigation and current management trends. Aust Fam Physician 2016;45:722\u20135."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_067","doi-asserted-by":"crossref","unstructured":"Champaneria, R, Abedin, P, Daniels, J, Balogun, M, Khan, KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 2010;89:1374\u201384. https:\/\/doi.org\/10.3109\/00016349.2010.512061.","DOI":"10.3109\/00016349.2010.512061"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_068","doi-asserted-by":"crossref","unstructured":"Singh, SS, Belland, L. Contemporary management of uterine fibroids: focus on emerging medical treatments. Curr Med Res Opin 2015;31:1\u20132. https:\/\/doi.org\/10.1185\/03007995.2014.982246.","DOI":"10.1185\/03007995.2014.982246"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_069","doi-asserted-by":"crossref","unstructured":"Dueholm, M, Lundorf, E, Hansen, ES, Ledertoug, S, Olesen, F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002;186:409\u201315. https:\/\/doi.org\/10.1067\/mob.2002.121725.","DOI":"10.1067\/mob.2002.121725"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_070","doi-asserted-by":"crossref","unstructured":"Ferenczy, A. Pathophysiology of adenomyosis. Hum Reprod Update 1998;4:312\u201322, https:\/\/doi.org\/10.1093\/humupd\/4.4.312.","DOI":"10.1093\/humupd\/4.4.312"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_071","doi-asserted-by":"crossref","unstructured":"Murray, H, Baakdah, H, Bardell, T, Tulandi, T. Diagnosis and treatment of ectopic pregnancy. Can Med Assoc 2005;173:905\u201312. https:\/\/doi.org\/10.1503\/cmaj.050222.","DOI":"10.1503\/cmaj.050222"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_072","doi-asserted-by":"crossref","unstructured":"Ellenson, LH, Ronnett, BM, Soslow, RA, Zaino, RJ, Kurman, RJ. Endometrial carcinoma. Blaustein\u2019s pathology of the female genital tract 2011:394\u2013452.","DOI":"10.1007\/978-1-4419-0489-8_9"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_073","doi-asserted-by":"crossref","unstructured":"Al Chami, A, Saridogan, E. Endometrial polyps and subfertility. J Obstet Gynaecol India 2017;67:9\u201314. https:\/\/doi.org\/10.1007\/s13224-016-0929-4.","DOI":"10.1007\/s13224-016-0929-4"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_074","doi-asserted-by":"crossref","unstructured":"Cramer, DW, Missmer, SA. The epidemiology of endometriosis. Ann NY Acad Sci 2002;955:11\u201322. https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb02761.x.","DOI":"10.1111\/j.1749-6632.2002.tb02761.x"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_075","unstructured":"Tanha, FD, Feizabad, E, Farahani, MV, Amuzegar, H, Moradi, B, Sadeh, SS. The effect of vitamin D deficiency on overgrowth of uterine fibroids: a blinded randomized clinical trial. Int J Fertil Steril 2021;15:95. https:\/\/doi.org\/10.22074\/IJFS.2020.134567."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_076","doi-asserted-by":"crossref","unstructured":"Arjeh, S, Darsareh, F, Asl, ZA, Kutenaei, MA. Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial. Compl Ther Clin Pract 2020;39:101159. https:\/\/doi.org\/10.1016\/j.ctcp.2020.101159.","DOI":"10.1016\/j.ctcp.2020.101159"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_077","doi-asserted-by":"crossref","unstructured":"Bottomley, C, Bourne, T. Diagnosis and management of ovarian cyst accidents. Best Pract Res Clin Obstet Gynaecol 2009;23:711\u201324. https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.02.001.","DOI":"10.1016\/j.bpobgyn.2009.02.001"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_078","doi-asserted-by":"crossref","unstructured":"De Waal, YR, Thomas, CM, Oei, AL, Sweep, FC, Massuger, LF. Secondary ovarian malignancies: frequency, origin, and characteristics. Int J\u00a0Gynecol Cancer 2009;19. https:\/\/doi.org\/10.1111\/igc.0b013e3181b33cce.","DOI":"10.1111\/IGC.0b013e3181b33cce"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_079","doi-asserted-by":"crossref","unstructured":"Geomini, P, Kruitwagen, R, Bremer, GL, Cnossen, J, Mol, BW. The accuracy of risk scores in predicting ovarian malignancy: a systematic review. Obstet Gynecol 2009;113:384\u201394. https:\/\/doi.org\/10.1097\/aog.0b013e318195ad17.","DOI":"10.1097\/AOG.0b013e318195ad17"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_080","doi-asserted-by":"crossref","unstructured":"Granberg, S, Gjelland, K, Ekerhovd, E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 2009;23:667\u201378. https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.01.010.","DOI":"10.1016\/j.bpobgyn.2009.01.010"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_081","doi-asserted-by":"crossref","unstructured":"Obed, JY, Bako, B, Usman, JD, Moruppa, JY, Kadas, S. Uterine fibroids: risk of recurrence after myomectomy in a Nigerian population. Arch Gynecol Obstet 2011;283:311\u20135. https:\/\/doi.org\/10.1007\/s00404-010-1355-y.","DOI":"10.1007\/s00404-010-1355-y"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_082","doi-asserted-by":"crossref","unstructured":"Metwally, M, Raybould, G, Cheong, YC, Horne, AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2020;1:1\u201342. https:\/\/doi.org\/10.1002\/14651858.CD003857.","DOI":"10.1002\/14651858.CD003857.pub4"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_083","unstructured":"De La Cruz, MS, Buchanan, EM. Uterine fibroids: diagnosis and treatment. Am Fam Physician 2017;95:100\u20137."},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_084","doi-asserted-by":"crossref","unstructured":"Candiani, M, Izzo, S. Laparoscopic versus vaginal hysterectomy for benign pathology. Curr Opin Obstet Gynecol 2010;22:304\u20138. https:\/\/doi.org\/10.1097\/gco.0b013e32833beab9.","DOI":"10.1097\/GCO.0b013e32833beab9"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_085","doi-asserted-by":"crossref","unstructured":"Reidy, J, Hacking, N, McLucas, B, editors. Radiological interventions in obstetrics and Gynaecology. Heidelberg: Springer; 2014.","DOI":"10.1007\/978-3-642-27975-1"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_086","doi-asserted-by":"crossref","unstructured":"Gupta, JK, Sinha, A, Lumsden, MA, Hickey, M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2014;12.","DOI":"10.1002\/14651858.CD005073.pub4"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_087","doi-asserted-by":"crossref","unstructured":"Napoli, A, Anzidei, M, Ciolina, F, Marotta, E, Marincola, BC, Brachetti, G, et al.. MR-guided high-intensity focused ultrasound: current status of an emerging technology. Cardiovasc Intervent Radiol 2013;36:1190\u2013203. https:\/\/doi.org\/10.1007\/s00270-013-0592-4.","DOI":"10.1007\/s00270-013-0592-4"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_088","doi-asserted-by":"crossref","unstructured":"Clark, NA, Mumford, SL, Segars, JH. Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence. Curr Opin Obstet Gynecol 2014;26:151. https:\/\/doi.org\/10.1097\/gco.0000000000000070.","DOI":"10.1097\/GCO.0000000000000070"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_089","doi-asserted-by":"crossref","unstructured":"Jacoby, VL, Kohi, MP, Poder, L, Jacoby, A, Lager, J, Schembri, M, et al.. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril 2016;105:773\u201380. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.11.014.","DOI":"10.1016\/j.fertnstert.2015.11.014"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_090","doi-asserted-by":"crossref","unstructured":"Kim, YS, Lim, HK, Park, MJ, Rhim, H, Jung, SH, Sohn, I, et al.. Screening magnetic resonance imaging\u2013based prediction model for assessing immediate therapeutic response to magnetic resonance imaging\u2013guided high-intensity focused ultrasound ablation of uterine fibroids. Invest Radiol 2016;51:15\u201324. https:\/\/doi.org\/10.1097\/rli.0000000000000199.","DOI":"10.1097\/RLI.0000000000000199"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_091","doi-asserted-by":"crossref","unstructured":"Thiburce, AC, Frulio, N, Hocquelet, A, Maire, F, Salut, C, Balageas, P, et al.. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the Sonalleve system. Int J Hyperther 2015;31:764\u201370. https:\/\/doi.org\/10.3109\/02656736.2015.1063169.","DOI":"10.3109\/02656736.2015.1063169"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_092","doi-asserted-by":"crossref","unstructured":"Lozinski, T, Filipowska, J, Gurynowicz, G, Gabriel, I, Czekierdowski, A. Non-invasive therapeutic use of high-intensity focused ultrasound (HIFU) with 3 tesla magnetic resonance imaging in women with symptomatic uterine fibroids. Ginekol Pol 2017;88:497\u2013503. https:\/\/doi.org\/10.5603\/gp.a2017.0091.","DOI":"10.5603\/GP.a2017.0091"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_093","doi-asserted-by":"crossref","unstructured":"Khan, AT, Shehmar, M, Gupta, JK. Uterine fibroids: current perspectives. Int J Womens Health 2014;6:95. https:\/\/doi.org\/10.2147\/ijwh.s51083.","DOI":"10.2147\/IJWH.S51083"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_094","doi-asserted-by":"crossref","unstructured":"Leminen, H, Hurskainen, R. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health 2012;4:413. https:\/\/doi.org\/10.2147\/ijwh.s13840.","DOI":"10.2147\/IJWH.S13840"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_095","doi-asserted-by":"crossref","unstructured":"Bradley, LD, Gueye, NA. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol 2016;214:31\u201344. https:\/\/doi.org\/10.1016\/j.ajog.2015.07.044.","DOI":"10.1016\/j.ajog.2015.07.044"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_096","doi-asserted-by":"crossref","unstructured":"Begam, AJ, Jubie, S, Nanjan, MJ. Estrogen receptor agonists\/antagonists in breast cancer therapy: a critical review. Bioorg Chem 2017;71:257\u201374. https:\/\/doi.org\/10.1016\/j.bioorg.2017.02.011.","DOI":"10.1016\/j.bioorg.2017.02.011"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_097","doi-asserted-by":"crossref","unstructured":"Patel, HK, Bihani, T. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther 2018;186:1\u201324. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.12.012.","DOI":"10.1016\/j.pharmthera.2017.12.012"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_098","doi-asserted-by":"crossref","unstructured":"Nelson, ER, Wardell, SE, McDonnell, DP. The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis. Bone 2013;53:42\u201350. https:\/\/doi.org\/10.1016\/j.bone.2012.11.011.","DOI":"10.1016\/j.bone.2012.11.011"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_099","doi-asserted-by":"crossref","unstructured":"Vilos, GA, Allaire, C, Laberge, PY, Leyland, N, Vilos, AG, Murji, A, et al.. The management of uterine leiomyomas. J Obstet Gynaecol Can 2015;37:157\u201378. https:\/\/doi.org\/10.1016\/s1701-2163(15)30338-8.","DOI":"10.1016\/S1701-2163(15)30338-8"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_100","doi-asserted-by":"crossref","unstructured":"Islam, MS, Afrin, S, Jones, SI, Segars, J. Selective progesterone receptor modulators\u2014mechanisms and therapeutic utility. Endocr Rev 2020;41. https:\/\/doi.org\/10.1210\/endrev\/bnaa012.","DOI":"10.1210\/endrev\/bnaa012"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_101","doi-asserted-by":"crossref","unstructured":"Kashani, BN, Centini, G, Morelli, SS, Weiss, G, Petraglia, F. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 2016;34:85\u2013103. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.016.","DOI":"10.1016\/j.bpobgyn.2015.11.016"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_102","doi-asserted-by":"crossref","unstructured":"Ali, M, Chaudhry, ZT, Al-Hendy, A. Successes and failures of uterine leiomyoma drug discovery. Expet Opin Drug Discov 2018;13:169\u201377. https:\/\/doi.org\/10.1080\/17460441.2018.1417381.","DOI":"10.1080\/17460441.2018.1417381"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_103","doi-asserted-by":"crossref","unstructured":"Leichtle, SW, Mouawad, NJ, Lampman, R, Singal, B, Cleary, RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J Am Coll Surg 2011;212:187\u201394. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2010.09.013.","DOI":"10.1016\/j.jamcollsurg.2010.09.013"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_104","doi-asserted-by":"crossref","unstructured":"Ning, G, Zhang, X, Zhang, Q, Wang, Z, Liao, H. Real-time and multimodality image-guided intelligent HIFU therapy for uterine fibroid. Theranostics 2020;10:4676. https:\/\/doi.org\/10.7150\/thno.42830.","DOI":"10.7150\/thno.42830"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_105","doi-asserted-by":"crossref","unstructured":"Moore, C, Jokerst, JV. Strategies for image-guided therapy, surgery, and drug delivery using photoacoustic imaging. Theranostics 2019;9:1550\u201371. https:\/\/doi.org\/10.7150\/thno.32362.","DOI":"10.7150\/thno.32362"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_106","doi-asserted-by":"crossref","unstructured":"Liao, H, Noguchi, M, Maruyama, T, Muragaki, Y, Kobayashi, E, Iseki, H, et al.. An integrated diagnosis and therapeutic system using intra-operative 5-Aminolevulinic-Acid-Induced fluorescence guided robotic laser ablation for precision neurosurgery. Med Image Anal 2012;16:754\u201366. https:\/\/doi.org\/10.1016\/j.media.2010.11.004.","DOI":"10.1016\/j.media.2010.11.004"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_107","doi-asserted-by":"crossref","unstructured":"Hunsche, S, Sauner, D, Majdou, FE, Neudorfer, C, Poggenborg, J, Go\u00dfmann, A, et al.. Intensity-based 2D 3D registration for lead localization in robot guided deep brain stimulation. Phys Med Biol 2017;62:2417\u201326. https:\/\/doi.org\/10.1088\/1361-6560\/aa5ecd.","DOI":"10.1088\/1361-6560\/aa5ecd"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_108","doi-asserted-by":"crossref","unstructured":"Koizumi, N, Lee, D, Seo, J, Funamoto, T, Sugita, N, Yoshinaka, K, et al.. Technologizing and digitalizing medical professional skills for a non-invasive ultrasound theragnostic system-technologizing and digitalizing kidney stone extraction skills. Asme\/iscie Int Symp Flexible Autom 2012:71\u20136.","DOI":"10.1115\/ISFA2012-7118"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_109","doi-asserted-by":"crossref","unstructured":"Seo, J, Koizumi, N, Funamoto, T, Sugita, N, Yoshinaka, K, Nomiya, A, et al.. Visual servoing for a US-guided therapeutic HIFU system by coagulated lesion tracking: a phantom study. Int J Med Robot Comp 2011;7:237\u201347. https:\/\/doi.org\/10.1002\/rcs.394.","DOI":"10.1002\/rcs.394"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_110","doi-asserted-by":"crossref","unstructured":"Fallahi, A, Pooyan, M, Ghanaati, H, Oghabian, MA, Khotanlou, H, Shakiba, M, et al.. Uterine segmentation and volume measurement in uterine fibroid patients\u2019 MRI using fuzzy C-mean algorithm and morphological operations. Iran J Radiol 2011;8:150\u20136. https:\/\/doi.org\/10.5812\/kmp.iranjradiol.17351065.3142.","DOI":"10.5812\/kmp.iranjradiol.17351065.3142"},{"key":"2025121209125772149_j_jbcpp-2022-0219_ref_111","doi-asserted-by":"crossref","unstructured":"Chapiro, J, Duran, R, Lin, MD, Werner, JD, Wang, Z, Schernthaner, R, et al.. Three-dimensional quantitative assessment of uterine fibroid response after uterine artery embolization using contrast-enhanced MR imaging. J Vsc Interv Radiol 2015;26:670\u20138.e2. https:\/\/doi.org\/10.1016\/j.jvir.2014.11.020.","DOI":"10.1016\/j.jvir.2014.11.020"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0219\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:49:21Z","timestamp":1765540161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2022-0219\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":111,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,20]]},"published-print":{"date-parts":[[2023,5,10]]}},"alternative-id":["10.1515\/jbcpp-2022-0219"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2022-0219","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"value":"0792-6855","type":"print"},{"value":"2191-0286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}